The WHO said Friday it had for the first time prequalified an mpox vaccine -- a move expected to speed up access to the jabs to fight an epidemic raging in Africa.
MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMARepresents the second EMA approval of an MVA-BN-based vaccine for a younger ...
Results that may be inaccessible to you are currently showing.